Dipak Jain and James G. Conley co-authored Chapter 9 titled “Patent expiry and pharmaceutical market opportunities at the nexus of pricing and innovation policy” in this publication. The paper explores the academic literature and empirical evidence associated with the strategic and tactical opportunities available to pharmaceutical firms confronted with the loss of patent protection on their branded drug.

>> Click here to order <<